Is HZNP a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Horizon Therapeutics PLC (HZNP) is 103.46 USD. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on DCF is -11.0%. This means that HZNP is a sell according to the DCF valuation model.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.9% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 66.49 - 251.13 | 103.46 |
| Upside | -42.8% - 115.9% | -11.0% |